These data are consistent with previous studies showing that only a minority of BRCA1-mutated breast cancers have high ER expression rates or overexpress c-erbB2 [24], and that most BRCA-mutated tumors are high-grade and have a higher proliferation fraction compared with sporadic tumors [25, 26]. This evidence concerns the gene ESR1 and breast carcinoma.